Natural History Study of Patients With Neurofibromatosis Type I
N/A
Background:
Neurofibromatosis Type 1 (NF1) is a genetic disorder in which ...
Status
Active Not Recruiting
Location
National Institutes of Health Clinical Center
Start Date
2008-02-25
Trial ID
NCT00924196
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
PHASE3
This phase III trial compares the effect of adding cabozantinib to avelumab...
Testing the Combination of Belinostat and SGI-110 (Guadecitabine) or ASTX727 for the Treatment of Unresectable and Metastatic Conventional Chondrosarcoma
PHASE2
This phase II trial studies the effect of belinostat and SGI-110 (guadecita...
Testing the Safety and Efficacy of the Combination of Two Anti-cancer Drugs, ZEN003694 and Abemaciclib, for Adult and Pediatric Patients (12-17 Years) With Metastatic or Unresectable NUT Carcinoma, Breast Cancer and Other Solid Tumors
PHASE1
This phase I trial tests the safety, side effects, and best dose of ZEN0036...
A Pilot Study of Immunotherapy Including Haploidentical NK Cell Infusion Following CD133+ Positively-Selected Autologous Hematopoietic Stem Cells in Children With High Risk Solid Tumors or Lymphomas
PHASE1
This is a pilot clinical trial investigating the addition of haploidentical...
Biology Guided Therapy Recommendations for Treatment Determination of Hormone Receptor-Positive Advanced, Unresectable or Metastatic Breast Cancer, ENDORSE Trial
PHASE1
This clinical trial tests the feasibility and utility of a biology guided t...